News in brief - March 2014 (updated)

Other new launches, licence changes and updates relevant to general practice.

Botox has received two new licence extensions, in addition to its current uses in migraine, urinary incontinence, muscle dystonias and numerous skin conditions.
Botox has received two new licence extensions, in addition to its current uses in migraine, urinary incontinence, muscle dystonias and numerous skin conditions.
  • The licence for Botox has been extended to include the treatment of ankle disability due to lower limb spasticity associated with stroke in adults and for the treatment of moderate to severe crow's feet lines seen at maximum smile in adults, when these have an important psychological impact.
  • The TNF inhibitor Cimzia (certolizumab pegol) can now be used to treat active psoriatic arthritis, in combination with methotrexate, when the response to DMARDs has been inadequate.
  • Intermittent supply problems with Enbrel (etanercept) pre-filled syringes and pens are anticipated until mid-April.
  • Olena is a new dispersible tablet formulation of the SSRI fluoxetine.
  • Patients being treated with Esmya (ulipristal acetate) for uterine fibroids can now receive a second three-month course if required.
  • The pre-filled syringe Metoject (methotrexate) can now be prescribed for patents with mild to moderate Crohn's disease, alone or in combination with corticosteroids, when treatment with thiopurines is inadequate.
  • The intravenous antibiotic Doribax (doripenem), used to treat nosocomial pneumonia and complicated abdominal and urinary tract infections, has been withdrawn for commercial reasons. 
  • NaTHNaC advises that a booster dose of polio-containing vaccine is no longer needed for travel to Benin, Burkina Faso, Burundi, Ghana, Kyrgyzstan, Myanmar, Sudan, South Sudan, Togo or Uzbekistan.

Follow MIMS on Twitter

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases